Gene · 5641
Papers1,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PCSK9 Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study. | J Invest Dermatol | 2025 | 39127093 | PubTator, text mining | PubMed |
| SERPINB7 Deficiency Increases Legumain Activity and Impairs the Epidermal Barrier in Nagashima-Type Palmoplantar Keratoderma. | J Invest Dermatol | 2025 | 38909841 | PubTator, text mining | PubMed |
| Inhibition of human tumor cell migration by a rice-derived chimeric cysteine protease inhibitor. | An Acad Bras Cienc | 2024 | 39699541 | PubTator, text mining | PubMed |
| Site-specific incorporation of 19F-nulcei at protein C-terminus to probe allosteric conformational transitions of metalloproteins. | Commun Biol | 2024 | 39627324 | PubTator, text mining | PubMed |
| An efficient and easily obtainable butelase variant for chemoenzymatic ligation and modification of peptides and proteins. | Microb Cell Fact | 2024 | 39614317 | PubTator, text mining | PubMed |
| Gastrointestinal tract cleavage of α-synuclein by asparaginyl endopeptidase leads to Parkinson's disease. | Neuron | 2024 | 39510038 | PubTator, text mining | PubMed |
| Enzyme/pH-sensitive nanoparticles based on poly(β-L-malic acid) for drug delivery with enhanced endocytosis. | J Mater Chem B | 2024 | 39428822 | PubTator, text mining | PubMed |
| Regulation of the NF-κB/NLRP3 signalling pathway by Shenghui Yizhi decoction reduces neuroinflammation in mice with Alzheimer's disease. | Ann Med | 2024 | 39391949 | PubTator, text mining | PubMed |
| Proteomic Characterization of Ubiquitin Carboxyl-Terminal Hydrolase 19 Deficient Cells Reveals a Role for USP19 in the Secretion of Lysosomal Proteins. | Mol Cell Proteomics | 2024 | 39389361 | PubTator, text mining | PubMed |
| Legumain is a paracrine regulator of osteoblast differentiation and mediates the inhibitory effect of TGF-β1 on osteoblast maturation. | Front Endocrinol (Lausanne) | 2024 | 39363898 | PubTator, text mining | PubMed |
| Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment. | Neurobiol Dis | 2024 | 39353514 | PubTator, text mining | PubMed |
| Lysosomal Proteases and Their Inhibitors. | Int J Mol Sci | 2024 | 39337555 | PubTator, text mining | PubMed |
| Information literacy and intention to adopt e-pharmacy: a study based on trust and the theory of reasoned action. | BMC Health Serv Res | 2024 | 39118124 | PubTator, text mining | PubMed |
| Legumain in cardiovascular diseases. | Exp Biol Med (Maywood) | 2024 | 39104790 | PubTator, text mining | PubMed |
| Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 Polarization. | Pharmaceuticals (Basel) | 2024 | 39065799 | PubTator, text mining | PubMed |
| Correction for: Blockage of AEP attenuates TBI-induced tau hyper-phosphorylation and cognitive impairments in rats. | Aging (Albany NY) | 2024 | 39037886 | PubTator, text mining | PubMed |
| Role of legumain in metabolic dysfunction, diagnosis, and prognosis of patients with atherosclerosis. | Medicine (Baltimore) | 2024 | 39029045 | PubTator, text mining | PubMed |
| Unraveling dynamic immunological landscapes in intracerebral hemorrhage: insights from single-cell and spatial transcriptomic profiling. | MedComm (2020) | 2024 | 38988493 | PubTator, text mining | PubMed |
| Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics. | J Control Release | 2024 | 38971427 | PubTator, text mining | PubMed |
| Assessment of circulating proteins in thyroid cancer: Proteome-wide Mendelian randomization and colocalization analysis. | iScience | 2024 | 38947504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5641/papers?page=6